1. Home
  2. ARQQ vs RAPP Comparison

ARQQ vs RAPP Comparison

Compare ARQQ & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQQ
  • RAPP
  • Stock Information
  • Founded
  • ARQQ 2017
  • RAPP 2022
  • Country
  • ARQQ United Kingdom
  • RAPP United States
  • Employees
  • ARQQ N/A
  • RAPP N/A
  • Industry
  • ARQQ Computer Software: Prepackaged Software
  • RAPP
  • Sector
  • ARQQ Technology
  • RAPP
  • Exchange
  • ARQQ Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • ARQQ 531.6M
  • RAPP 439.4M
  • IPO Year
  • ARQQ N/A
  • RAPP 2024
  • Fundamental
  • Price
  • ARQQ $30.41
  • RAPP $14.97
  • Analyst Decision
  • ARQQ Strong Buy
  • RAPP Strong Buy
  • Analyst Count
  • ARQQ 1
  • RAPP 3
  • Target Price
  • ARQQ $52.00
  • RAPP $33.67
  • AVG Volume (30 Days)
  • ARQQ 366.1K
  • RAPP 161.7K
  • Earning Date
  • ARQQ 05-22-2025
  • RAPP 08-07-2025
  • Dividend Yield
  • ARQQ N/A
  • RAPP N/A
  • EPS Growth
  • ARQQ N/A
  • RAPP N/A
  • EPS
  • ARQQ 0.48
  • RAPP N/A
  • Revenue
  • ARQQ $241,000.00
  • RAPP N/A
  • Revenue This Year
  • ARQQ $284.30
  • RAPP N/A
  • Revenue Next Year
  • ARQQ $415.45
  • RAPP N/A
  • P/E Ratio
  • ARQQ $62.97
  • RAPP N/A
  • Revenue Growth
  • ARQQ N/A
  • RAPP N/A
  • 52 Week Low
  • ARQQ $3.72
  • RAPP $6.43
  • 52 Week High
  • ARQQ $52.79
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • ARQQ 42.70
  • RAPP 52.13
  • Support Level
  • ARQQ $27.29
  • RAPP $14.30
  • Resistance Level
  • ARQQ $32.00
  • RAPP $16.10
  • Average True Range (ATR)
  • ARQQ 2.04
  • RAPP 1.17
  • MACD
  • ARQQ -0.18
  • RAPP -0.02
  • Stochastic Oscillator
  • ARQQ 38.00
  • RAPP 43.53

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: